Technical Analysis for ASRT - Assertio Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 4.87 0.83% 0.04
ASRT closed up 0.83 percent on Friday, March 22, 2019, on 1.2 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ASRT trend table...

Date Alert Name Type % Chg
Mar 22 Calm After Storm Range Contraction 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Above Upper BB Strength 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Up 3 Days in a Row Strength 0.00%
Mar 22 Up 4 Days in a Row Strength 0.00%
Mar 22 Up 5 Days in a Row Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Calm After Storm Range Contraction 0.83%
Mar 21 Stochastic Reached Overbought Strength 0.83%

Older signals for ASRT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution), Xartemis XR and Zipsor (diclofenac potassium). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.
Pharmaceutical Pain Organ Systems Chemical Compounds Organic Compounds Analgesics Migraine Treatment Of Migraine Diabetic Peripheral Neuropathy Diclofenac Postherpetic Neuralgia
Is ASRT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.48
52 Week Low 3.37
Average Volume 621,436
200-Day Moving Average 5.6843
50-Day Moving Average 4.2706
20-Day Moving Average 4.255
10-Day Moving Average 4.331
Average True Range 0.2746
ADX 19.03
+DI 29.5411
-DI 12.1364
Chandelier Exit (Long, 3 ATRs ) 4.1862
Chandelier Exit (Short, 3 ATRs ) 4.5638
Upper Bollinger Band 4.8576
Lower Bollinger Band 3.6524
Percent B (%b) 1.01
BandWidth 28.324324
MACD Line 0.1166
MACD Signal Line 0.0182
MACD Histogram 0.0984
Fundamentals Value
Market Cap 306.75 Million
Num Shares 63 Million
EPS -1.79
Price-to-Earnings (P/E) Ratio -2.72
Price-to-Sales 0.75
Price-to-Book 1.50
PEG Ratio 0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.26
Resistance 3 (R3) 5.26 5.14 5.19
Resistance 2 (R2) 5.14 5.04 5.13 5.17
Resistance 1 (R1) 5.00 4.98 5.07 5.00 5.15
Pivot Point 4.88 4.88 4.91 4.88 4.88
Support 1 (S1) 4.74 4.78 4.81 4.74 4.59
Support 2 (S2) 4.62 4.72 4.62 4.57
Support 3 (S3) 4.48 4.62 4.55
Support 4 (S4) 4.48